Research Papers

25 of 10972 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Choosing the Right Antibiotic in Ambulatory Care.
Anderson VL; Miskinis-Hilligoss D.
J Nurse Pract (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Cumulative Chapter Titles Keyword Index, Vol. 1-41.
NA
Annu Rep Med Chem (Unknown)
Published: 2006
Compound Name, Code Number and Subject Index. Vol. 41.
NA
Annu Rep Med Chem (Unknown)
Published: 2006
Developing Infectious Disease Strategies for the Developing World.
Lee PJ; Krilov LR.
Annu Rep Med Chem (Unknown)
Published: 2006
Neuropharmacologic Approaches to Cognitive Rehabilitation.
Klein R; McNamara P; Albert ML.
Behav Neurol (Unknown)
Published: 2006
Codon usage patterns in Nematoda: analysis based on over 25 million codons in thirty-two species.
Mitreva M; Wendl MC; Martin J; Wylie T; Yin Y; Larson A; Parkinson J; Waterston RH; McCarter JP.
Genome Biol (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Neuropathological alterations in drug abusers : The involvement of neurons, glial, and vascular systems.
Büttner A; Weis S.
Forensic Sci Med Pathol (Unknown)
Published: 2006
Characterizing phenotype with tracer based metabolomics.
Lee WN.
Metabolomics (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
<i>Ab initio</i> prediction of metabolic networks using Fourier transform mass spectrometry data.
Breitling R; Ritchie S; Goodenowe D; Stewart ML; Barrett MP.
Metabolomics (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Assessing the performance of statistical validation tools for megavariate metabolomics data.
Rubingh CM; Bijlsma S; Derks EP; Bobeldijk I; Verheij ER; Kochhar S; Smilde AK.
Metabolomics (Unknown)
Published: 2006
PNU-91325 increases fatty acid synthesis from glucose and mitochondrial long chain fatty acid degradation: a comparativ…
Harrigan GG; Colca J; Szalma S; Boros LG.
Unknown Journal
Published: 2006
New modes of data partitioning based on PARS peak alignment for improved multivariate biomarker/biopattern detection in…
Torgrip RJ; Lindberg J; Linder M; Karlberg B; Jacobsson SP; Kolmert J; Gustafsson I; Schuppe-Koistinen I.
Metabolomics (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Introducing infectious agents and cancer.
Buonaguro FM; Lewis GK; Pelicci P.
Infect Agent Cancer (Unknown)
Published: 2006
How should we describe the benefits of palliative radiotherapy?
Samant R; Tucker T.
Unknown Journal
Published: 2006
The use of prophylactic anticonvulsants in patients with brain tumours-a systematic review.
Perry J; Zinman L; Chambers A; Spithoff K; Lloyd N; Laperriere N; Neuro-oncology Disease Site Group; Cancer Care Ontario’s Program in Evidence-Based Care.
Curr Oncol (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Recommendations of the canadian consensus group on the management of chronic myeloid leukemia.
Laneuville P; Barnett MJ; Bélanger R; Couban S; Forrest DL; Roy DC; Lipton JH.
Curr Oncol (Unknown)
Published: 2006
1/6 Transparent
Retinoids, vitamin D, invasion, and metastasis.
Tokar EJ; Ablin RJ; Webber MM.
Curr Oncol (Unknown)
Published: 2006
The cancer patient's wife.
Handelman M.
Curr Oncol (Unknown)
Published: 2006
Celebrating a year of change and progress.
McLean M.
Curr Oncol (Unknown)
Published: 2006
Receptor tyrosine kinases: role in cancer progression.
Sangwan V; Park M.
Curr Oncol (Unknown)
Published: 2006
Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?
Gainford MC; Dranitsaris G; Ooi W; Vanhuyse M; Clemons M.
Curr Oncol (Unknown)
Published: 2006
Promising agents for chemoprevention of skin cancer.
Stratton SP; Stratton MS; Alberts DS.
Curr Oncol (Unknown)
Published: 2006
Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced c…
Jonker D; Rumble RB; Maroun J; Gastrointestinal Cancer Disease Site Groupof Cancer Care Ontario’s Program in Evidence-Based Care.
Curr Oncol (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
Reece D; Imrie K; Stevens A; Smith CA; Hematology Disease Site Groupof Cancer Care Ontario’s Program in Evidence-based Care.
Curr Oncol (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Recent advances in adjuvant systemic treatment for breast cancer: all systems go!
Fishman PN; Verma S.
Curr Oncol (Unknown)
Published: 2006
1/6 Transparent
Funding Declared